Ben R. Taylor
CFO & President of Recursion UKMr. Ben R. Taylor served as the Chief Financial Officer and Executive Director of Exscientia Limited and Exscientia plc since November 2020 and also served as its Chief Strategy Officer since 2021. He joined Exscientia in November 2020. He has experience, including in healthcare investment banking, primarily at Goldman Sachs & Co. LLC, or Goldman Sachs and seven years in biotech and healthtech executive roles. During this period, Mr. Taylor focused on strategy, financings, communications, clinical development and business development in the biopharmaceutical industry. Prior to joining Exscientia, he was interim Chief Financial Officer at Aetion, Inc., a healthtech company using real world data analytics to optimise biopharma clinical development and commercialisation, from April 2020 to November 2020. He served as President and Chief Financial Officer for Tyme Technologies, Inc., where he oversaw operations for the oncology company from April 2017 to August 2020. Mr. Taylor served as Head of Commercial Pharma, Managing Director for Barclays Capital Inc. from February 2016 to March 2017 and in a variety of roles with Goldman Sachs from July 2006 to February 2016. Mr. Taylor is CFO & President of Recursion UK of Recursion Pharmaceuticals, Inc. since joining in it November 20, 2024. He received a B.A. with Honors from Brown University in East Asian Studies.
Positions
- Company NameRecursion Pharmaceuticals, Inc.Stock CodeRXRXPositionCFO & President of Recursion UKColleagues
- NKNajat KhanCEO, President & Director
- FHFred HassanChair of the Board
- BMBenjamin MabeyChief Technology Officer
- DHDavid HallettChief Scientific Officer
- NHNathan HatfieldChief Legal Officer & Corporate Secretary
- ZDZavain DarIndependent Director
- RMRobert M. HershbergIndependent Director
- JPJoseph P. MiletichChairman of Therapeutics Advisory Board
